Evidence map›Paper›PMID 29667786›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2018

Frailty phenotypes and mortality after lung transplantation: A prospective cohort study.

Jonathan P Singer, Joshua M Diamond, Michaela R Anderson, Patricia P Katz, Ken Covinsky, Michelle Oyster, Tatiana Blue, Allison Soong, Laurel Kalman, Pavan Shrestha and 19 more

2 registry-linked trialsAbstract readMulticenter Study
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03895931 completednot on this mapstarted 2019, after this paper: background citation

Effects of Pulmonary Rehabilitation on Frailty in Candidates for Lung Transplantation - a Prospective Observational Study

TypeobservationalSponsorSchön Klinik Berchtesgadener LandRan2019 to 2020Enrolled30ConditionsAdvanced Lung Disease, COPD, ILD
NCT04184180 completednot on this mapstarted 2019, after this paper: background citation

Effects of an Inpatient Pulmonary Rehabilitation Programme on Frailty in Patients After Lung-Transplantation

TypeobservationalSponsorKlaus KennRan2019 to 2020Enrolled33ConditionsAdvanced Lung Disease, COPD, Interstitial Lung Disease
3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Observational
  4. Frailty in Pulmonary Arterial Hypertension: A Cohort Study.Annals of the American Thoracic Society · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frailty in lung transplant recipients is associated with anemia and telomere dysfunction but independent of epigenetic age.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Lung transplantation for interstitial lung disease.Breathe (Sheffield, England) · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Poor functional status at the time of waitlist for pediatric lung transplant is associated with worse pretransplant outcomes.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Jonathan P SingerDepartment of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0003-0224-7472
Joshua M DiamondDepartment of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Michaela R AndersonDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Patricia P KatzDepartment of Medicine, University of California, San Francisco, CA, USA.
Ken CovinskyDepartment of Medicine, University of California, San Francisco, CA, USA.
Michelle OysterDepartment of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Tatiana BlueDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Allison SoongDepartment of Medicine, University of California, San Francisco, CA, USA.
Laurel KalmanDepartment of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Pavan ShresthaDepartment of Medicine, University of California, San Francisco, CA, USA.
Selim M ArcasoyDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
John R GreenlandDepartment of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0003-1422-8367
Lori ShahDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Jasleen KukrejaDepartment of Surgery, University of California, San Francisco, CA, USA.
Nancy P BlumenthalPenn Transplant Institute, University of Pennsylvania, Philadelphia, PA, USA.
Imaani EasthausenDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Jeffrey A GoldenDepartment of Medicine, University of California, San Francisco, CA, USA.
Amika McBurnieDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Ed CantuDepartment of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Joshua SonettDepartment of Surgery, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Steven HaysDepartment of Medicine, University of California, San Francisco, CA, USA.
Hilary RobbinsDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Kashif RazaDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Matthew BacchettaDepartment of Surgery, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Rupal J ShahDepartment of Medicine, University of California, San Francisco, CA, USA.
Frank D'OvidioDepartment of Surgery, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Aida VenadoDepartment of Medicine, University of California, San Francisco, CA, USA.
Jason D ChristieDepartment of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
David J LedererDepartment of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.ORCID 0000-0001-5258-0228

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
CTSA: K12 COMPONENTKL2RR024130 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$19.3M
Clinical Risk Factors for Primary Graft DysfunctionR01HL087115 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D · 2007 to 2017
$7.1M
Genetics of primary graft dysfunctionR01HL081619 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D · 2007 to 2011
$3.9M
Frailty and patient centered outcomes in candidates for lung transplantationR01HL134851 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SINGER, JONATHAN PAUL · 2017 to 2021
$3.4M
Obesity, Inflammation, and Lung Injury After Lung TransplantationR01HL114626 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHRISTIE, JASON D, LEDERER, DAVID J. · 2013 to 2016
$3.1M
Role of anti-Col (V) immunity in primary graft dysfunctionR01HL096845 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D, WILKES, DAVID S · 2010 to 2013
$2.2M
Mentored Patient Oriented Research in Lung TransplantationK24HL115354 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHRISTIE, JASON D · 2012 to 2021
$1.2M
Lung Transplant donor: prediction, evaluation, and mechanismK23HL116656 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CANTU, EDWARD · 2013 to 2017
$872k
The Effects of Lung Transplant on Disability and Health-Related Quality of LifeK23HL111115 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SINGER, JONATHAN PAUL · 2012 to 2016
$832k
Long Pentraxin-3 genomics and outcomes after lung transplantationK23HL121406 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI DIAMOND, JOSHUA M. · 2014 to 2017
$629k
CSRD VA IK2 CX001034NCATS NIH HHS UL1 TR000040NCRR NIH HHS KL2 RR024130NCRR NIH HHS UL1 RR024131NHLBI NIH HHS K23 HL111115NHLBI NIH HHS K23 HL116656NHLBI NIH HHS K23 HL121406NHLBI NIH HHS K24 HL115354NHLBI NIH HHS K24 HL131937NHLBI NIH HHS R01 HL081619NHLBI NIH HHS R01 HL087115NHLBI NIH HHS R01 HL096845NHLBI NIH HHS R01 HL114626NHLBI NIH HHS R01 HL134851NHLBI NIH HHS R03 HL135227
6 · The paper itself

Abstract

Frailty is associated with increased mortality among lung transplant candidates. We sought to determine the association between frailty, as measured by the Short Physical Performance Battery (SPPB), and mortality after lung transplantation. In a multicenter prospective cohort study of adults who underwent lung transplantation, preoperative frailty was assessed with the SPPB (n = 318) and, in a secondary analysis, the Fried Frailty Phenotype (FFP; n = 299). We tested the association between preoperative frailty and mortality following lung transplantation with propensity score-adjusted Cox models. We calculated postestimation marginalized standardized risks for 1-year mortality by frailty status using multivariate logistic regression. SPPB frailty was associated with an increased risk of both 1- and 4-year mortality (adjusted hazard ratio [aHR]: 7.5; 95% confidence interval [CI]: 1.6-36.0 and aHR 3.8; 95%CI: 1.8-8.0, respectively). Each 1-point worsening in SPPB was associated with a 20% increased risk of death (aHR: 1.20; 95%CI: 1.08-1.33). Frail subjects had an absolute increased risk of death within the first year after transplantation of 12.2% (95%CI: 3.1%-21%). In secondary analyses, FFP frailty was associated with increased risk of death within the first postoperative year (aHR: 3.8; 95%CI: 1.1-13.2) but not over longer follow-up. Preoperative frailty is associated with an increased risk of death after lung transplantation.

Indexed as

Postoperative ComplicationsQuality of LifeSeverity of Illness IndexAgedFemaleFollow-Up StudiesFrailtyHumansLung DiseasesLung TransplantationMaleMiddle AgedPhenotypePrognosisProspective StudiesRisk Factorsclinical research/practicelung transplantation/pulmonologypatient survivalrecipient selection

Identifiers

PMID29667786
PMCPMC6105397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.